People / Staff

Moira Garraus Oneca

Search publications

Publications

  • Mora J, Castañeda-Heredia A, Colombo MC, Gorostegui M, Fernando Gómez Muñoz, Mañe S, Santa-María López V, Garraus-Oneca M, Macias N, Pérez-Jaume S, Muñoz-Aznar O, Muñoz JP, Barber-Martínez de la Torre I and Suñol M.

    Clinical and Pathological Evidence of Anti-GD2 Immunotherapy Induced Differentiation in Relapsed/Refractory High-Risk Neuroblastoma

    Cancers . 13(6): 164. Number of citations: 14

    [doi:10.3390/cancers13061264]

  • Mora J, Castañeda-Heredia A, Flores MA, Santa-María V, Garraus-Oneca M, Gorostegui M, Simao M, Pérez-Jaume S and Mañe S.

    The Role of Autologous Stem-Cell Transplantation in High-Risk Neuroblastoma Consolidated by anti-GD2 Immunotherapy. Results of Two Consecutive Studies

    Frontiers in Pharmacology . 11: 575009-575009. Number of citations: 17

    [doi:10.3389/fphar.2020.575009]

  • Inarejos E, Navallas M, Barber Martínez de la Torre I, Suñol M, Munuera-del Cerro JL, Torner F, Garraus-Oneca M and Navarro OM.

    MRI of Rhabdomyosarcoma and Other Soft-Tissue Sarcomas in Children

    RADIOGRAPHICS . 40(3): 791-814. Number of citations: 59

    [doi:10.1148/rg.2020190119]

  • Ortega-Bertran S, Fernández-Rodríguez J, Magallón-Lorenz M, Creus-Bachiller E, Uriarte-Arrazola I, Mazuelas H, Garraus-Oneca M, Carrió M, Gel B, Rovira-Zurriaga C, Alvarez M, Villanueva A, Castañeda-Heredia A, Salvador-Hernandez H, Serra E and Lázaro C.

    Personalized medicine strategy for MPNSTs: using precision oncology on PDOX models to inform tumor boards.

    Journal of Translational Medicine . : .

    [doi:10.1186/s12967-026-07751-9]